Family history of hematopoietic malignancy and risk of lymphoma

Journal of the National Cancer Institute

Volumn 97, Issue 19, 2005, Pages 1466-1474

  Chang, Ellen T ^a   Smedby, Karin Ekström ^a   Hjalgrim, Henrik ^b   Porwit MacDonald, Anna ^a   Roos, Göran ^c   Glimelius, Bengt ^a,d   Adami, Hans Olov ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c UMEÅ UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; FAMILY HISTORY; FOLLICULAR LYMPHOMA; HEMATOLOGIC MALIGNANCY; HIGH RISK POPULATION; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; BLOOD DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HODGKIN DISEASE; INCIDENCE; MALE; MEDICAL RECORD; MIDDLE AGED; REGISTER; RISK; RISK FACTOR; STATISTICAL MODEL; SWEDEN;

ADULT; AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HODGKIN DISEASE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LOGISTIC MODELS; LYMPHOMA, FOLLICULAR; LYMPHOMA, NON-HODGKIN; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; MULTIPLE MYELOMA; ODDS RATIO; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SWEDEN;

EID: 26944455977     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji293     Document Type: Article

References (43)

1. Obrams GI, O'Conor G. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Time trends and pathological classification: A summary. Cancer Res 1992;52:5570s.
2. Banks PM. Changes in diagnosis of non-Hodgkin's lymphomas over time. Cancer Res 1992;52:5453s-5s.
3. Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 1992;52:5566s-9s.
4. Vose JM, Chiu BC, Cheson BD, Dancey J, Wright J. Update on epidemiology and therapeutics for non-Hodgkin's lymphoma. Hematology (Am Soc Hematol Educ Program) 2002:241-62.
5. Mueller NE, Grufferman S. The epidemiology of Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, editors. Hodgkin's disease. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 61-77.
6. Cuttner J. Increased incidence of hematologic malignancies in first-degree relatives of patients with chronic lymphocytic leukemia. Cancer Investig 1992;10:103-9.
7. Linet MS, Pottern LM. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma. Cancer Res 1992;52:5468s-73s.
8. Shpilberg O, Modan M, Modan B, Chetrit A, Fuchs Z, Ramot B. Familial aggregation of haematological neoplasms: A controlled study. Br J Haematol 1994;87:75-80.
9. Paltiel O, Schmit T, Adler B, Rachmilevitz EA, Polliack A, Cohen A, et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: Results and limitations of a registry-linked study. Cancer 2000;88:2357-66.
10. Hemminki K, Mutanen P. Parental cancer as a risk factor for nine common childhood malignancies. Br J Cancer 2001;84:990-3.
11. Hemminki K, Czene K. Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 2002;11: 1638-44.
12. Chiu BC, Weisenburger DD, Zahm SH, Cantor KP, Gapstur SM, Holmes F, et al. Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004;13:525-31.
13. Chatterjee N, Hartge P, Cerhan JR, Cozen W, Davis S, Ishibe N, et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 2004;13:1415-21.
14. Domingo-Domenech E, Benavente Y, Alvaro T, Hernandez M, de Sevilla AF, de Sanjose S. Family clustering of blood cancers as a risk factor for lymphoid neoplasms. Haematologica 2005;90:416-8.
15. Altieri A, Bermejo JL, Hemminki K. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: The Swedish Family-Cancer Database. Blood 2005;106:668-72.
16. Razis DV, Diamond HD, Craver LF. Familial Hodgkin's disease: Its significance and implications. Ann Intern Med 1959;51:933-71.
17. Grufferman S, Cole P, Smith PG, Lukes RJ. Hodgkin's disease in siblings. N Engl J Med 1977;296:248-50.
18. Grufferman S, Barton JW III, Eby NL. Increased sex concordance of sibling pairs with Behcet's disease, Hodgkin's disease, multiple sclerosis, and sarcoidosis. Am J Epidemiol 1987;126:365-9.
19. Mack TM, Cozen W, Shibata DK, Weiss LM, Nathwani BN, Hernandez AM, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995;332:413-8.
20. Goldin LR, Pfeiffer RM, Gridley G, Gail MH, Li X, Mellemkjaer L, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 2004;100:1902-8.
21. Zhu K, Levine RS, Brann EA, Gu Y, Caplan LS, Hall I, et al. Risk factors for non-Hodgkin's lymphoma according to family history of haematolymphoproliferative malignancies. Int J Epidemiol 2001;30:818-24.
22. Chiu BC, Weisenburger DD, Cantor KP, Zahm SH, Holmes F, Burmeister LF, et al. Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodgkin's lymphoma in men. Ann Epidemiol 2002;12:309-15.
23. Ekström Smedby K, Hjalgrim H, Melbye M, Torrång A, Rostgaard K, Munksgaard L, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005;97:199-209.
24. International statistical classification of diseases and related health problems, 1989 revision. Geneva (Switzerland): World Health Organization; 1992.
25. Swedish Cancer Register. Cancer incidence in Sweden 1998. Stockholm (Sweden): Centre for Epidemiology; 2000.
26. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. WHO classification of tumours: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon (France): International Agency for Research on Cancer (IARC) Press; 2001.
27. Statistics Sweden. The multi-generation register. Örebro (Sweden): Statistics Sweden; 2004.
28. Report of the International Conference for the Seventh Revision of the International Lists of Diseases and Causes of Death. Geneva (Switzerland): World Health Organization; 1955.
29. Physical status: The use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854: 1-452.
30. Chang ET, Ekström Smedby K, Zhang SM, Hjalgrim H, Melbye M, Öst Å, et al. Dietary factors and risk of non-Hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev 2005;14:512-20.
31. Chang ET, Ekström Smedby K, Zhang SM, Hjalgrim H, Melbye M, Öst Å, et al. Alcohol intake and risk of non-Hodgkin lymphoma in men and women. Cancer Causes Control 2004;15:1067-76.
32. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966; 26:1189-201.
33. Gutensohn NM. Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the "two-disease hypothesis." Cancer Treatment Rep 1982;66:689-95.
34. Alexander FE, McKinney PA, Williams J, Ricketts TJ, Cartwright RA. Epidemiological evidence for the 'two-disease hypothesis' in Hodgkin's disease. Int J Epidemiol 1991;20:354-61.
35. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995;310:1491-5.
36. Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 1995;141:916-22.
37. Swerdlow AJ, Storm HH, Sasieni PD. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 1995;61:773-9.
38. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 1996;125:815-21.
39. Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996;74:1847-50.
40. Reik W, Walter J. Genomic imprinting: Parental influence on the genome. Nat Rev Genet 2001;2:21-32.
41. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer incidence in five continents. IARC scientific publication no. 155. Vol VIII. Lyon (France): International Association for Research on Cancer (IARC); 2003.
42. Shugart YY. Anticipation in familial Hodgkin lymphoma. Am J Hum Genet 1998;63:270-2.
43. Shugart YY, Hemminki K, Vaittinen P, Kingman A. Apparent anticipation and heterogeneous transmission patterns in familial Hodgkin's and non-Hodgkin's lymphoma: Report from a study based on Swedish cancer database. Leuk Lymphoma 2001;42:407-15.